The week at Retraction Watch featured a look at where retractions for fake peer review come from, and an eyebrow-raising plan that has a journal charging would-be whistleblowers a fee. Here’s what was happening elsewhere:
The week at Retraction Watch featured news of a fine for a doctor who took part in a controversial fake trial, and a likely unprecedented call for retraction by the U.S. FDA commissioner. Here’s what was happening elsewhere:
Mario Saad, a diabetes researcher who once sued to stop a publisher from retracting his papers, has just received his eighth retraction. Critical Care has retracted a 2012 paper about treating sepsis, citing extensive similarities between figures within the paper and 10 others. Here’s the full notice for “Diacerhein attenuates the inflammatory response and improves … Continue reading Researcher who sued to stop retractions earns his 8th
The week at Retraction Watch featured a shooting by a researcher fired for misconduct, and the creation of fake computer-generated peer reviews. Here’s what was happening elsewhere:
A prominent researcher in Scotland has been suspended amidst a misconduct investigation at the University of Dundee. According to The Scotsman, the allegations against Robert Ryan center around falsifying data and duplicating figures in his work about molecular bacteriology. As the outlet reports:
The week at Retraction Watch featured health care fraud charges for a researcher who committed scientific fraud, and a first-ever government agency lawsuit against a scientific publisher for deceit. Here’s what was happening elsewhere:
A tribunal in the UK has rejected an appeal by Queen Mary University of London, who sought to reverse a previous order that they release data from a controversial 2011 paper in The Lancet about chronic fatigue syndrome (CFS). The decision is one in a long series of judgments about the so-called PACE trial, which reported … Continue reading UK tribunal orders release of data from controversial chronic fatigue syndrome study
The week at Retraction Watch featured an inscrutable retraction notice, and a raft of new retractions for a cancer researcher who once threatened to sue us. Here’s what was happening elsewhere:
PLOS ONE has retracted three papers after the first author admitted to submitting the manuscripts without co-authors’ consent, and an investigation suggested that two out of the three papers had received faked reviews. Last August, the same author — Lishan Wang of the Shanghai Jiao Tong University — lost two more papers (one in Tumor Biology and … Continue reading Author loses five papers, most for “compromised” peer review
Diabetes has issued two expressions of concern (EOCs) for papers co-authored by leading diabetes researcher Kathrin Maedler, adding to her previous count of one retraction and three corrections. Both papers were questioned on PubPeer, alongside several others co-authored by Maedler, who is based at the University of Bremen in Germany. As we previously reported, PubPeer comments have … Continue reading Journal flags two papers by prominent diabetes researcher, more questioned on PubPeer